Sanara MedTech Inc.
NASDAQ:SMTI
35.75 (USD) • At close September 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue
| 86.672 | 64.99 | 45.843 | 24.144 | 15.587 |
| Cost of Revenue
| 8.14 | 7.853 | 6.361 | 2.311 | 1.617 |
| Gross Profit
| 78.533 | 57.137 | 39.482 | 21.833 | 13.97 |
| Gross Profit Ratio
| 0.906 | 0.879 | 0.861 | 0.904 | 0.896 |
| Reseach & Development Expenses
| 5.703 | 4.132 | 3.367 | 0.559 | 0.04 |
| General & Administrative Expenses
| 0 | 0 | 45.976 | 28.053 | 18.684 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 76.56 | 56.995 | 45.976 | 28.053 | 18.684 |
| Other Expenses
| 2.985 | 0.225 | 2.371 | 0.597 | 0.251 |
| Operating Expenses
| 85.248 | 61.352 | 51.714 | 29.209 | 18.975 |
| Operating Income
| -6.715 | -4.215 | -12.232 | -7.376 | -5.035 |
| Operating Income Ratio
| -0.077 | -0.065 | -0.267 | -0.306 | -0.323 |
| Total Other Income Expenses Net
| -3.196 | -0.225 | -1.42 | -0.618 | 0.589 |
| Income Before Tax
| -9.912 | -4.44 | -13.937 | -7.994 | -4.445 |
| Income Before Tax Ratio
| -0.114 | -0.068 | -0.304 | -0.331 | -0.285 |
| Income Tax Expense
| 0.247 | 0 | -5.845 | 0 | 0 |
| Net Income
| -9.665 | -4.303 | -7.937 | -7.922 | -4.356 |
| Net Income Ratio
| -0.112 | -0.066 | -0.173 | -0.328 | -0.279 |
| EPS
| -1.14 | -0.52 | -1 | -1.08 | -0.76 |
| EPS Diluted
| -1.14 | -0.52 | -1 | -1.08 | -0.76 |
| EBITDA
| -1.86 | -0.289 | -9.674 | -7.221 | -4.025 |
| EBITDA Ratio
| -0.021 | -0.004 | -0.211 | -0.299 | -0.258 |